2/7
02:07 am
embc
Medium
Report
2/6
08:04 am
embc
Embecta (NASDAQ:EMBC) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $25.00 price target on the stock.
Medium
Report
Embecta (NASDAQ:EMBC) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $25.00 price target on the stock.
2/5
05:43 pm
embc
Embecta Q1 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Embecta Q1 Earnings Call Highlights [Yahoo! Finance]
2/5
03:47 pm
embc
Embecta Corp. (EMBC) Q1 2026 Earnings Call Transcript [Seeking Alpha]
Low
Report
Embecta Corp. (EMBC) Q1 2026 Earnings Call Transcript [Seeking Alpha]
2/5
03:47 pm
embc
Embecta outlines $1.71B–$1.93B revenue target for 2026 as GLP-1 partnerships gain traction [Seeking Alpha]
Low
Report
Embecta outlines $1.71B–$1.93B revenue target for 2026 as GLP-1 partnerships gain traction [Seeking Alpha]
2/5
02:11 pm
embc
Embecta Corp (EMBC) Q1 2026 Earnings Call Highlights: Strategic Progress Amidst Market Challenges [Yahoo! Finance]
Low
Report
Embecta Corp (EMBC) Q1 2026 Earnings Call Highlights: Strategic Progress Amidst Market Challenges [Yahoo! Finance]
2/5
06:30 am
embc
Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results
Medium
Report
Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results
2/5
06:27 am
embc
Embecta declares $0.15 dividend [Seeking Alpha]
Medium
Report
Embecta declares $0.15 dividend [Seeking Alpha]
2/5
06:00 am
embc
embecta Announces Quarterly Cash Dividend
Medium
Report
embecta Announces Quarterly Cash Dividend
1/22
05:00 pm
embc
embecta to Report Fiscal First Quarter Financial Results
Medium
Report
embecta to Report Fiscal First Quarter Financial Results
12/27
01:05 am
embc
Low
Report
12/18
05:00 pm
embc
embecta to Participate at the J.P. Morgan 2026 Healthcare Conference
Low
Report
embecta to Participate at the J.P. Morgan 2026 Healthcare Conference
11/29
09:30 am
embc
Embecta Growth Stalls Despite Strong Fiscal 2025 Results (Rating Downgrade) [Seeking Alpha]
Low
Report
Embecta Growth Stalls Despite Strong Fiscal 2025 Results (Rating Downgrade) [Seeking Alpha]
11/29
12:31 am
embc
Low
Report
11/25
12:16 pm
embc
Embecta (NASDAQ:EMBC) had its "buy" rating reaffirmed by analysts at BTIG Research.
Low
Report
Embecta (NASDAQ:EMBC) had its "buy" rating reaffirmed by analysts at BTIG Research.
11/25
11:26 am
embc
Embecta Corp. (EMBC) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Neutral
Report
Embecta Corp. (EMBC) Q4 2025 Earnings Call Transcript [Seeking Alpha]
11/25
11:25 am
embc
Embecta outlines $100M GLP-1 revenue opportunity by 2033 as company advances global brand transition [Seeking Alpha]
Neutral
Report
Embecta outlines $100M GLP-1 revenue opportunity by 2033 as company advances global brand transition [Seeking Alpha]
11/25
08:24 am
embc
Embecta declares $0.15 dividend [Seeking Alpha]
Low
Report
Embecta declares $0.15 dividend [Seeking Alpha]
11/25
06:53 am
embc
embecta Announces Quarterly Cash Dividend [Yahoo! Finance]
Medium
Report
embecta Announces Quarterly Cash Dividend [Yahoo! Finance]
11/25
06:30 am
embc
Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance
Medium
Report
Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance
11/25
06:00 am
embc
embecta Announces Quarterly Cash Dividend
Medium
Report
embecta Announces Quarterly Cash Dividend
11/17
05:00 pm
embc
embecta announces changes to Board of Directors
Low
Report
embecta announces changes to Board of Directors
11/14
06:30 am
embc
embecta Announces Major New Commitment to Direct Relief on World Diabetes Day
Low
Report
embecta Announces Major New Commitment to Direct Relief on World Diabetes Day
11/11
05:00 pm
embc
embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results
Low
Report
embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results